Ming Tan
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Cancer, Hypoxia, and Metabolism 16
- MicroRNA in disease regulation 16
- Oncology 34
- HER2/EGFR in Cancer Research 16
- Co-authors
- Dihua Yu (17 shared papers)Jianrong Lu (12 shared papers)Ethan B. Butler (3 shared papers)Yinglan Zhao (1 shared paper)Qingsong Cai (3 shared papers)Mien‐Chie Hung (5 shared papers)Øystein Fodstad (13 shared papers)Xiaoyan Zhou (4 shared papers)
- Journals
- PLoS ONE (9 papers)Cell Death and Disease (8 papers)Cancer Research (8 papers)Oncotarget (7 papers)Journal of Biological Chemistry (6 papers)
- Partner nations
- United StatesChinaMalaysia
In The Last Decade
Ming Tan
195 papers receiving 14k citations
Ming Tan's Hit Papers
Peers
Comparison fields: 5 of 165
- Cancer Research 3.5k
- Oncology 3.4k
- Molecular Biology 4k
- Nephrology 447
- Health Informatics 89
Countries citing papers authored by Ming Tan
This map shows the geographic impact of Ming Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Tan more than expected).
Fields of papers citing papers by Ming Tan
This network shows the impact of papers produced by Ming Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Tan. The network helps show where Ming Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 204 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients Hit paper breakdown → | 2004 | 1523 |
| 2 | Targeting cellular metabolism to improve cancer therapeutics Hit paper breakdown → | 2013 | 856 |
| 3 | The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism Hit paper breakdown → | 2014 | 646 |
| 4 | 2004 | 460 | |
| 5 | 1996 | 417 | |
| 6 | 2018 | 370 | |
| 7 | 2010 | 366 | |
| 8 | 2010 | 343 | |
| 9 | 1998 | 318 | |
| 10 | 2004 | 263 | |
| 11 | 2011 | 251 | |
| 12 | 2011 | 236 | |
| 13 | The role of ChatGPT in scientific communication: writing better scientific review articles. Hit paper breakdown → | 2023 | 230 |
| 14 | 2009 | 225 | |
| 15 | 2011 | 215 | |
| 16 | 2017 | 215 | |
| 17 | Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. | 1997 | 192 |
| 18 | 2012 | 192 | |
| 19 | Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. | 1996 | 190 |
| 20 | 2017 | 173 |
About Ming Tan
Ming Tan is a scholar working on Cancer Research, Oncology, Molecular Biology, Complementary and alternative medicine and Pharmacology, having authored 204 papers that have together received 14.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (16 papers), Cancer, Hypoxia, and Metabolism (16 papers), MicroRNA in disease regulation (16 papers), Biomedical Text Mining and Ontologies (11 papers), Head and Neck Cancer Studies (8 papers), Autophagy in Disease and Therapy (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Acute Myeloid Leukemia Research (6 papers). The work is most often cited by research in Cancer Research (3.5k citations), Oncology (3.4k citations), Molecular Biology (4k citations), Nephrology (447 citations) and Health Informatics (89 citations). Ming Tan has collaborated with scholars based in United States, China and Malaysia. Frequent co-authors include Dihua Yu, Jianrong Lu, Ethan B. Butler, Yinglan Zhao, Qingsong Cai, Mien‐Chie Hung, Øystein Fodstad, Xiaoyan Zhou, Keng‐Hsueh Lan and Kristine S. Klos. Their work appears in journals such as PLoS ONE, Cell Death and Disease, Cancer Research, Oncotarget and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.